Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs.
Bossa F, Carparelli S, Latiano A, Palmieri O, Tavano F, Panza A, Pastore M, Marseglia A, D'Altilia M, Latiano T, Corritore G, Martino G, Nardella M, Guerra M, Terracciano F, Sacco M, Perri F, Andriulli A.
Bossa F, et al. Among authors: andriulli a.
Dig Liver Dis. 2021 Mar;53(3):277-282. doi: 10.1016/j.dld.2020.12.120. Epub 2021 Jan 6.
Dig Liver Dis. 2021.
PMID: 33423942
Free PMC article.